Mode
Text Size
Log in / Sign up
N/A N=189 Randomized Single-blind Treatment

A Study to Compare the NexGen CR and CR-Flex Knee Implants

Total Knee Arthroplasty · Osteoarthritis

Enrolled (actual)
189
Serious AEs
1.6%
Results posted
Jul 2012
Primary outcome: Primary: Postoperative Range of Motion (ROM) — 119.1; 120.7 degrees

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
NexGen CR-Flex Fixed Bearing Knee (Device); NexGen CR Knee (Device)
Age
Adult, Older Adult · 21+ yrs
Sex
All
Sponsor
Zimmer Biomet
Primary completion
Dec 2010

Outcome Measures

OutcomeResultp-value
PRIMARY
Postoperative Range of Motion (ROM)
119.1; 120.7
SECONDARY
Return to Function (RtF) Via Knee Scoiety Score (Modified)
80.9; 85.1

Summary

The purpose of this study is to test for significant differences in functional outcomes, specifically pre-operative ROM and post-operative ROM obtained by using a NexGen CR versus a NexGen CR-Flex knee implant. Specifically, it is predicted that an increase in post-operative range of motion will be experienced by patients treated with the NexGen CR-Flex knee implant.

Eligibility Criteria

Inclusion Criteria

  • Age, 21-80 years
  • Sex, Male and Females will be included
  • BMI less than or equal to 39
  • Stable Health, the patient would be able to undergo surgery and participate in a follow-up program based on physical examination and medical history.
  • Patient is willing and able to cooperate in follow-up therapy.
  • Patient exhibits pre-operative radiographic evidenced of joint degeneration consistent with TKA that cannot be treated in non-operative fashion.
  • Patient has stable and functional posterior cruciate and collateral ligaments.
  • Patient has potential to perform higher than average range of motion activities.
  • Operative side range of motion flexion greater than or equal to 120 degrees.
  • Severe knee pain and disability due to degenerative joint disease.
  • Patient or patient's legal representative has signed the Informed Consent form.

Exclusion Criteria

  • Previous history of infection in the affected joint.
  • Previously failed knee endoprosthesis of any kind.
  • Charcot joint disease or other severe neurosensory deficits.
  • Previous patellectomy
  • Patient is skeletally immature.
  • Grossly insufficient femoral or tibial bone stock.
  • Patient is pregnant.
  • Varus or valgus deformity greater than 20 degrees.
  • Fixed flexion deformity greater than 15 degrees.
  • Previous high tibial osteotomy.
  • Previous femoral osteotomy.
  • Patient is a poor compliance risk, currently treated for ethanol or drug abuse, physical or mental handicap, etc.
  • Loss of musculature or absence of musculoligamentous supporting structures required for adequate soft tissue balance.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00761956). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search